Blog

May 18, 2026

What DEA Manufacturing License Holders Must Know About Drug Diversion

Supply Chain Drug Diversion Prevention: What DEA Manufacturing License Holders Must Know The diversion of drugs remains one of the most serious risks within pharmaceutical... Read More

May 15, 2026

Blind Spots in Plain Sight: The Value of an Unbiased Compliance Review

How TITAN’s Third-Party Audits Help Facilities Stay Ahead An organization’s approach to regulatory compliance is often shaped by familiarity. Processes evolve, workarounds... Read More

May 11, 2026

Vets’ Biennial Inventory Blunders —And How to Avoid Them

TITAN Group’s DEA compliance experts – former DEA Diversion Investigators – saw countless violations of the Controlled Substance Act (CSA) during their many years of... Read More

May 11, 2026

The Drug Supply Chain Security Act Explained: What Pharmacies and Manufacturers Must Know

The pharmaceutical supply chain is under increasing scrutiny as regulators and industry leaders work to combat counterfeit drugs, diversion, and other vulnerabilities that... Read More

May 4, 2026

Medetomidine: What Pharmacies Must Do Now

Medetomidine: The Next Dangerous Threat in the Illicit Drug Supply & What Pharmacies Must Do Now The opioid crisis continues to evolve in ways that make it increasingly... Read More

March 10, 2026

The New DEA Reality for EMS: What Changed on March 9, 2026 — and What It Means for Your Agency

Effective March 9, 2026, EMS agencies officially became DEA registrants. Read More

March 6, 2026

Theft and Significant Loss of Controlled Substances - Understanding Federal and State Reporting Requirements

Controlled substances are tightly regulated because they carry a high potential for abuse, diversion, and misuse. When a theft or significant loss occurs, the risk to public... Read More

March 6, 2026

What Triggers a DEA Inspection? Key Factors Every Registrant Should Understand

A DEA inspection can feel intimidating, but in most cases, inspections don’t happen “out of the blue.” They’re usually triggered by internally identifiable signals, patterns,... Read More

February 5, 2026

How to Prevent Drug Diversion in Veterinary Practices: Compliance Strategies That Work

Drug diversion is a growing risk in veterinary clinics, where controlled substances such as opioids, sedatives, and anesthetics are routinely handled as part of patient care.... Read More

January 7, 2026

Drug Diversion in Pharmacy: 7 Warning Signs You Should Know

Drug diversion in pharmacy settings poses a serious and growing risk to patient safety, regulatory compliance, and organizational integrity. At its core, pharmacy diversion... Read More

January 7, 2026

Inventory Management Best Practices: The Role of Automation and Technology in Tracking Controlled Substances

Controlled substance inventory management is under increasing scrutiny as regulators, healthcare organizations, and enforcement agencies work to curb diversion and strengthen... Read More

January 7, 2026

Understanding DEA Guidelines for Pain Management​: Ensuring Safe and Legal Practices

Pain management plays a vital role in improving patients’ quality of life, helping those suffering from acute or chronic pain regain comfort, mobility, and function. Yet,... Read More

January 7, 2026

Common Drug Disposal Mistakes That Put Your DEA Registration at Risk

Well-meaning practitioners just like you – from veterinarians to dentists to pharmacists – can sometimes be their own worst enemies when it comes to compliance with DEA... Read More

October 27, 2025

4 Key Aspects of DEA Diversion Training for Dentists

In a dental practice, the safe handling of controlled substances is a crucial part of good clinical practice. It’s a legal and ethical necessity. Read More

October 27, 2025

How Titan Groups Helps Dentists Prescribing Opioids Stay DEA Compliant

The opioid crisis has led to heightened scrutiny from the DEA, with stricter oversight on how controlled substances are prescribed and monitored. While opioids can play an... Read More